Case Reports in Medicine

Case Reports in Medicine / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 3132654 | 4 pages | https://doi.org/10.1155/2016/3132654

ST Segment Elevation with Normal Coronaries

Academic Editor: Michael S. Firstenberg
Received28 Feb 2016
Accepted22 May 2016
Published15 Jun 2016

Abstract

Noncardiac causes should be kept in the differential while evaluating ST elevation on EKG. Rarely abdominal pathologies like acute pancreatitis can present with ST elevation in the inferior leads. Once acute coronary syndrome is ruled out by emergent cardiac catheterization alternative diagnosis should be sorted. Abdominal pathologies, like acute pancreatitis and acute cholecystitis, can present with ST elevation in the inferior leads. Treating the underlying condition would result in resolution of these EKG changes.

1. Introduction

Chest pain accounts for around 6 million annual visits to emergency department (ED) in the United States (US) [1]. Electrocardiogram and troponin level are one of the common modalities used to rule out any acute coronary events in these patients. Patients with abnormal electrocardiogram (EKG), troponin level, and risk factors are referred for undergoing coronary catheterization. In one study 26% of angiography done in acute phase of suspected STEMI was normal [2]. Chest pain in these cases might be secondary to other cardiac conditions other than acute coronary events or extracardiac causes. We present three such cases with extracardiac cause of abnormal EKG and troponin levels who had normal coronaries on catheterization.

2. Case  1

56-year-old lady with a history of hypertension, dyslipidemia, and gallstones presented to the emergency department (ED) with severe stinging, nonradiating, midsternal chest pain ongoing for 45 minutes. She experienced nausea, vomiting, and diaphoresis. She denied palpitations, orthopnea, or paroxysmal nocturnal dyspnea. On physical exam she was hypotensive with BP of 80/50 mmHg and a heart rate of 117 bpm. Her lungs were clear and cardiac exam showed normal heart sounds with no murmurs or rubs. She had mild epigastric tenderness, but there was no guarding or rigidity and bowel sounds were heard. 12-lead electrocardiogram (EKG) showed 2 mm ST elevation in leads II, III, and AVF, with reciprocal changes in leads I and AVL (Figure 1). With the diagnosis of acute inferior ST elevation myocardial infarction, STEMI protocol was initiated and emergent heart catheterization showed minimal coronary disease without the need for percutaneous intervention. Her labs data returned in the interim with WBC of 12,000 with no shift, hemoglobin of 11 g/dL, hematocrit of 36%, potassium of 2.6 mg/dL, magnesium of 1.4 mg/dL, and calcium of 7.2 mg/dL. Her serial troponins were 6.0, 1.2, and 0.87. Her liver function tests (LFT) were elevated alanine transaminase (ALT), 398 U/L; aspartate transaminase (AST), 863 U/L; alkaline phosphatase (ALP), 328 U/L; and lipase, 9,080 U/L. Computed tomography (CT) of the abdomen showed diffusely edematous and inflamed pancreas (Figure 2). She was started on intravenous fluids and pain medicine and received nothing by mouth to treat her acute pancreatitis. Interestingly, on repeat EKG, the inferior ST elevations had resolved. Over the course of her hospital stay her chest pain improved and her biochemical markers, including LFT and lipase, trended downwards, and she was discharged.

3. Case  2

28-year-old gentleman, with no significant past medical history, was transferred from outside hospital with diagnosis of STEMI. He had presented to the outside facility with severe, sharp, stabbing, midsternal chest pain and epigastric pain radiating to his axilla and back. His social history was significant for daily alcohol use with an average of 5-6 beers/day. He admitted to binge drinking one day prior to admission. EKG at the outside facility showed ST segment elevation in leads II, III, AVF, V5, and V6 (Figure 3). He had troponin elevation up to 4. In our hospital he was taken for emergent cardiac catheterization which showed normal coronaries. In the interim other tested lab work showed lipase of 4256 units/L. CT of the abdomen was significant for peripancreatic stranding consistent with the diagnosis of acute pancreatitis (Figure 4). He was treated with intravenous fluid hydration and pain medicines. His serial troponins trended down to 1.95 and 0.86. His repeat EKG did not show ST elevation. Patient was discharged in stable condition.

4. Case  3

A 43-year-old lady with history of hypertension, gastroesophageal reflux, and morbid obesity presented to the ED with severe knife-like chest pain and abdominal pain which started one hour prior to presentation. On physical exam her BP was 200/100 mmHg, HR was 96 bpm, RR was 22 breaths, and temperature was 100.5 F. She was alert but looked pale and diaphoretic. On cardiac exam there were no murmurs. Abdominal exam revealed positive murphy sign and right upper quadrant tenderness. EKG showed ST segment elevation in leads II, III, and AVF with reciprocal changes in the lateral leads (Figure 5). Her troponins were minimally elevated at 0.66. STEMI protocol was initiated and she was taken for urgent cardiac catheterization in keeping with the door to balloon time of 90 minutes. Cardiac catheterization revealed normal coronaries. Other lab work done showed WBC count of 14,000; liver enzymes, amylase, and lipase were within normal limits. CT scan of abdomen was done given right upper quadrant pain which revealed emphysematous cholecystitis with no gall stones (Figure 6). Surgery was consulted and she underwent a cholecystectomy. Repeat EKG no longer showed the ST elevation. The patient was discharged in stable condition.

5. Discussion

It is imperative to rule out cardiac ischemia in patients who present with chest pain and ST segment elevation on EKG. Emergent cardiac catheterization is the standard of care. However, once a cardiac etiology is ruled out other diagnosis should be sought.

A 2.3% incidence of alternative conditions mimicking STEMI is found in patients referred for primary percutaneous coronary intervention (PCI) [3]. Various multisystem etiologies include cerebrovascular conditions like subarachnoid hemorrhage, pulmonary conditions such as pneumonia, pulmonary embolism, and COPD, and nonischemic cardiac causes like myocarditis, myopericarditis, and acute heart failure (Table 1). Abdominal causes like acute pancreatitis, cholecystitis, and peritonitis comprise 5% of cases of noncardiac STEMI mimics [3, 4].


NeurologicalSubarachnoid hemorrhage

CoronaryCoronary artery aneurysm, coronary artery occlusion, coronary artery stenosis, spontaneous coronary artery dissection, prinzmetal angina, cocaine abuse

CardiacPericarditis, myocarditis, perimyocarditis, Brugada syndrome, left ventricular hypertrophy, left bundle branch block, cardioversion, takotsubo cardiomyopathy, cardiac compression

VascularAortic dissection, pulmonary thromboembolism

PulmonaryPneumonia, COPD, mediastinal tumor

AbdominalCholecystitis, pancreatitis, hiatal hernia, subdiaphragmatic abscess, peritonitis

ElectrolytesHyperkalemia, hyper/hypophosphatemia

EndocrinePheochromocytoma, thyroid storm

Abdominal etiologies like pancreatitis and cholecystitis can also cause troponin elevation. Release of pancreatic proteolytic enzymes causing transient myonecrosis and coronary vasospasm has been the hypothesized pathophysiologic mechanism [5]. Various other medical conditions can cause mild troponin elevation as well. These include nonischemic cardiac causes like myopericarditis, acute heart failure, defibrillator shocks, and arrhythmias. Pulmonary causes include pulmonary embolism. Systemic causes like septic and anaphylactic shock can also cause troponin elevation (Table 2) [69, 1316]. This is usually secondary to left ventricular strain and demand ischemia rather than a coronary blockage.


Nonischemic cardiacMyocarditis, congestive heart failure, cardiac amyloidosis, cardiac contusion, closure of atrial septal defect, cardioversion and defibrillator shocks, supraventricular tachycardia

PulmonaryPulmonary thromboembolism

AbdominalCholecystitis, pancreatitis

RenalChronic renal failure

NeurologicalSubarachnoid hemorrhage, stroke

SystemicSeptic shock, sepsis, critically ill patient, scorpion envenoming, high dose chemotherapy

The electrocardiographic changes in patients with acute cholecystitis and pancreatitis which have been reported are mostly transient [4, 1012]. These changes usually are in the form of T-wave inversion, ST segment depression, and rarely ST segment elevation in the absence of coronary artery disease. The EKG changes in these patients are hypothesized to be secondary to changes in vagal nervous system. This also explains why EKG changes of ST elevation are mostly seen in inferior leads [10]. Other suggested mechanisms include cardiobiliary reflex, release of pancreatic proteolytic enzymes causing myonecrosis, transient coronary vasospasm, and any associated metabolic disturbances [4, 11, 12]. These EKG changes mostly resolve with the treatment of the underlying condition.

We did not perform echocardiogram in ED for our cases as emergent left heart catheterization was performed based on clinical presentation, EKG findings, and elevated troponins. However, echocardiogram can be helpful to improve the diagnostic specificity in selected cases. In patients having atypical chest pain, with ST elevation on EKG and/or troponin elevation where there is a clinical dilemma whether these patients need urgent catheterization or initial conservative management, echocardiographic assessment of ventricular function and wall motion abnormalities can help in further management. Absent wall motion abnormalities in patient with ongoing chest pain puts acute ST segment elevation myocardial infarction very low on differential. However, this must be balanced against the time delay necessary to obtain transthoracic echocardiogram and potential for ongoing myocardial injury.

6. Conclusion

Physicians should therefore consider intra-abdominal etiologies when faced with transient inferior ST segment elevations in patient without significant coronary disease.

Disclosure

Pooja Sethi is the first author and Ghulam Murtaza is the first co-author.

Competing Interests

The authors declare that they have no competing interests.

References

  1. L. McCaig and C. Burt, National Hospital Ambulatory Medical Care Survey: 2003 Emergency Department Summary, Advance Data from Vital and Health Statistics no. 358, Centers for Disease Control and Prevention, Atlanta, Ga, USA, 2005.
  2. P. Widimsky, B. Stellova, L. Groch et al., “Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies,” Canadian Journal of Cardiology, vol. 22, no. 13, pp. 1147–1152, 2006. View at: Publisher Site | Google Scholar
  3. Y. L. Gu, T. Svilaas, I. C. C. Van Der Horst, and F. Zijlstra, “Conditions mimicking acute ST-segment elevation myocardial infarction in patients referred for primary percutaneous coronary intervention,” Netherlands Heart Journal, vol. 16, no. 10, pp. 325–331, 2008. View at: Publisher Site | Google Scholar
  4. A. Rubio-Tapia, J. García-Leiva, E. Asensio-Lafuente, G. Robles-Díaz, and F. Vargas-Vorácková, “Electrocardiographic abnormalities in patients with acute pancreatitis,” Journal of Clinical Gastroenterology, vol. 39, no. 9, pp. 815–818, 2005. View at: Publisher Site | Google Scholar
  5. D. J. Fox, C. Grimm, and N. P. Curzen, “Raised troponin T in acute cholecystitis,” Journal of the Royal Society of Medicine, vol. 97, no. 4, article 179, 2004. View at: Publisher Site | Google Scholar
  6. Y. Sato, R. Taniguchi, K. Nagai et al., “Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy,” Heart, vol. 89, no. 6, pp. 659–660, 2003. View at: Publisher Site | Google Scholar
  7. K. Setsuta, Y. Seino, T. Ogawa, M. Arao, Y. Miyatake, and T. Takano, “Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure,” The American Journal of Medicine, vol. 113, no. 9, pp. 717–722, 2002. View at: Publisher Site | Google Scholar
  8. E. Missov, C. Calzolari, J.-M. Davy, F. Leclercq, M. Rossi, and B. Pau, “Cardiac troponin I in patients with hematologic malignancies,” Coronary Artery Disease, vol. 8, no. 8-9, pp. 537–541, 1997. View at: Google Scholar
  9. D. Cardinale, M. T. Sandri, A. Martinoni et al., “Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy,” Journal of the American College of Cardiology, vol. 36, no. 2, pp. 517–522, 2000. View at: Publisher Site | Google Scholar
  10. T. K. Ro, R. M. Lang, and R. P. Ward, “Acute pancreatitis mimicking myocardial infarction: evaluation with myocardial contrast echocardiography,” Journal of the American Society of Echocardiography, vol. 17, no. 4, pp. 387–390, 2004. View at: Publisher Site | Google Scholar
  11. A. C. Yu and D. L. Riegert-Johnson, “A case of acute pancreatitis presenting with electrocardiographic signs of acute myocardial infarction,” Pancreatology, vol. 3, no. 6, pp. 515–517, 2003. View at: Publisher Site | Google Scholar
  12. A. N. Makaryus, O. Adedeji, and S. K. Ali, “Acute pancreatitis presenting as acute inferior wall ST-segment elevations on electrocardiography,” American Journal of Emergency Medicine, vol. 26, no. 6, pp. 734.e1–734.e4, 2008. View at: Publisher Site | Google Scholar
  13. P. Ammann, M. Pfisterer, T. Fehr, and H. Rickli, “Raised cardiac troponins,” British Medical Journal, vol. 328, no. 7447, pp. 1028–1029, 2004. View at: Publisher Site | Google Scholar
  14. A. Dispenzieri, R. A. Kyle, M. A. Gertz et al., “Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins,” The Lancet, vol. 361, no. 9371, pp. 1787–1789, 2003. View at: Publisher Site | Google Scholar
  15. J. E. Adams III, V. G. Dávila-Román, P. Q. Bessey, D. P. Blake, J. H. Ladenson, and A. S. Jaffe, “Improved detection of cardiac contusion with cardiac troponin I,” American Heart Journal, vol. 131, no. 2, pp. 308–312, 1996. View at: Publisher Site | Google Scholar
  16. A. H. Madrid, J. M. Del Rey, J. Rubi et al., “Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: approach to size of necrosis,” American Heart Journal, vol. 136, no. 6, pp. 948–955, 1998. View at: Publisher Site | Google Scholar

Copyright © 2016 Pooja Sethi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

3660 Views | 514 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.